DeepCure Introduces Advanced STAT6 Inhibitor for Inflammation
DeepCure's STAT6 Inhibitor Program DeepCure, an innovative therapeutics company harnessing the power of artificial intelligence to unveil groundbreaking therapies for inflammation and immune diseases, has made an exciting announcement. The company recently revealed the development of potent and selective oral small molecule inhibitors designed to target STAT6, a key...
Continue Reading